Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our MissionDonald Metcalf (1929-2014)
Donald Metcalf, MD, is well known for his pioneering work on the regulation of blood cell formation. Beginning in 1965, he worked to co-develop specialized culture techniques for growing blood cells, which led to the discovery of colony-stimulating factors (CSFs), hormones that regulate white blood cell formation. Dr. Metcalf's work led to the successful cloning and mass production of CSFs, which can speed recovery in cancer patients following chemotherapy or radiation therapy.
Dr. Metcalf has received many prestigious honors during his career, including the Lasker Award for Clinical Medicine, the Louisa Gross Horwitz Prize of Columbia University, and the Jessie Stevenson Kovalenko Medal of the U.S. National Academy of Sciences.